MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 06-06-2026
Adamis Pharmaceuticals Corporation Operating Expenses 2011-2026 | ADMP
Annual Operating Expenses Adamis Pharmaceuticals Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 38.9 M | 35.7 M | 44.7 M | 30.3 M | 26.8 M | 13.9 M | 4.4 M | 3.22 M | 4.82 M | 6 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.7 M | 3.22 M | 20.9 M |
Operating Expenses of other stocks in the Drug manufacturers industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
763 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
15.5 M | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
35.2 M | $ 5.6 | - | $ 83.2 M | USA |
 |
HEXO Corp.
HEXO
|
106 M | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
381 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
40.3 M | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
44.6 M | - | - | $ 50.1 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
213 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
30.5 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
71.8 M | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
80.2 M | $ 2.63 | -1.87 % | $ 1.01 B | Canada |
 |
Athenex
ATNX
|
96.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
174 M | $ 38.93 | 3.43 % | $ 1.43 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
196 M | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
512 M | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
519 M | $ 2.41 | 2.99 % | $ 305 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
113 M | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
279 M | $ 22.74 | -1.09 % | $ 1.05 B | USA |
 |
Canopy Growth Corporation
CGC
|
197 M | $ 0.98 | -1.71 % | $ 105 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
9.18 M | $ 1.11 | 1.83 % | $ 1.38 M | USA |
 |
Aurora Cannabis
ACB
|
183 M | $ 2.95 | -2.96 % | $ 162 M | Canada |
 |
Solid Biosciences
SLDB
|
179 M | $ 7.36 | 3.08 % | $ 644 M | USA |
 |
Jupiter Wellness
JUPW
|
39.6 M | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
209 M | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
41.4 M | $ 1.03 | -2.83 % | $ 98.2 M | Canada |
 |
Tilray
TLRY
|
1.52 B | $ 5.01 | 0.6 % | $ 3.1 B | Canada |
 |
Evolus
EOLS
|
107 M | $ 6.75 | 0.3 % | $ 435 M | USA |
 |
Sundial Growers
SNDL
|
102 K | $ 1.43 | 0.7 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
558 M | $ 8.29 | -0.36 % | $ 444 M | USA |
 |
Veru
VERU
|
35.5 M | $ 3.13 | 4.33 % | $ 45.8 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
103 M | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
28.9 M | $ 0.67 | -2.33 % | $ 2.7 M | USA |
 |
Assertio Holdings
ASRT
|
133 M | $ 23.5 | 0.09 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
19.4 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
304 M | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
4.96 B | $ 4.99 | -1.38 % | $ 1.85 B | Canada |
 |
PetIQ
PETQ
|
138 M | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
59.1 M | $ 6.37 | -4.21 % | $ 251 M | USA |
 |
Recro Pharma
REPH
|
22.5 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
129 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
36.7 M | $ 4.09 | -3.31 % | $ 204 M | USA |
 |
PLx Pharma
PLXP
|
44.2 M | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
7.68 B | $ 16.32 | -0.97 % | $ 19 B | USA |
 |
Zomedica Corp.
ZOM
|
14.1 M | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
35.3 M | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
31.1 M | $ 0.64 | 2.74 % | $ 23 M | USA |
 |
Tricida
TCDA
|
153 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
3.11 M | $ 0.75 | 2.35 % | $ 3.22 M |  China |
 |
TherapeuticsMD
TXMD
|
7.41 M | $ 2.28 | 3.64 % | $ 26.4 M | USA |